At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 397 enrolled
Drug / intervention
Multi-Electrode RF Balloon Catheterdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Safety and Effectiveness Evaluation of the Multi-Electrode Radiofrequency Balloon Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation (STELLAR)
In Brief
A Phase 3 clinical trial evaluating Multi-Electrode RF Balloon Catheter for Atrial Fibrillation. Completed, enrolled 397 participants across 41 sites in 3 countries.
Detailed Summary
The primary objective of this clinical investigation is to demonstrate safety and effectiveness of the Multi-Electrode RF Balloon catheter for the treatment of drug refractory symptomatic paroxysmal atrial fibrillation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation
CountriesChina, Italy, United States
Collaborators--
Timeline
Phase 3CompletedFinished
20192020202120222023202420252026
First PostedSep 2018
Enrollment StartOct 2018
Primary CompletionFeb 2022
TodayJul 2026
First PostedSep 25, 2018
Enrollment StartOct 22, 2018
Primary CompletionFeb 18, 2022
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 7.8 years ago
Interventions
Multi-Electrode RF Balloon Catheterdevice
Multi-Electrode RF Balloon Catheter will be inserted